Prednisolone: A beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 1, 1999, Pages 47-54

  Bilaçeroǧlu, Semra ^a,b   Perim, K ^a   Buyuksirin M ^a   Celikten E ^a  

^a Izmir Chest Diseases and Surgery Training Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Prednisolone; Pulmonary tuberculosis; Toxic reactions

Indexed keywords

ALBUMIN; AMIKACIN; CIPROFLOXACIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PREDNISOLONE; PYRAZINAMIDE; STREPTOMYCIN;

ADULT; ANOREXIA; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FAILURE TO THRIVE; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 17044455289     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cullinan P, Meredith S K. Deaths in adults with notified pulmonary tuberculosis 1983-85. Thorax 1991; 46: 347-350.
2. Humphries M J, Byfield S P, Darbyshire J H, et al. Deaths occuring in the newly notified patients with pulmonary tuberculosis in England and Wales. Br J Dis Chest 1984; 78: 149-156.
3. Agarwal M K, Muthuswamy P P, Banner A S, et al. Septicemia in patients with bacteriologically positive pulmonary tuberculosis. JAMA 1977; 238; 2297-2299.
4. Barnes P F, Chan L S, Wong S F. The course of fever during treatment of pulmonary tuberculosis. Tubercle 1987; 68: 255-260.
5. Grau G E, Parida S T, Pointaire P, et al. TNF and mycobacteria. In: Beutler B, ed. Tumor necrosis factor: the molecules and their emerging role in medicine. New York: Raven Press, 1992.
6. Dofferhoff A M, Nijaland J H, de Vries Hospers H G, et al. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in vitro study. Scand J Infect Dis 1991; 23: 745-754.
7. Rich E A, Ellner J J. Pathogenesis of tuberculosis. In: Friedman L N, ed. Tuberculosis: current concepts and treatment. Boca Raton, FL: CRC Press, 1994: 27-51.
8. 2 by peripheral mononuclear cells from tuberculosis patients. Clin Exp Immunol 1990; 81: 319-324.
9. Atkins E, Francis L, Bernheim H A. Pathogenesis of fever in delayed hypersensitivity: role of monocytes. Infect Immun 1978; 21: 813.
10. Muthuswamy P, Hu T-C, Carasso B, Antonio M, Dandamudi N. Prednisone as adjunctive therapy in the management of pulmonary tuberculosis. Report of 12 cases and review of the literature. Chest 1995; 107: 1621-1630.
11. Barnes P F, Barrows S A. Tuberculosis in the 1990s. Ann Intern Med 1993; 119: 400-410.
12. Alzeer A H, FitzGerald J M. Corticosteroids and tuberculosis: risks and use as adjunct therapy. Tubercle Lung Dis 1993; 74: 6-11.
13. Ellis M E, Webb A K. Cause of death in patients admitted to hospital with pulmonary tuberculosis. Lancet 1983; I: 665-667.
14. Horn N W. Prednisone in the treatment of pulmonary tuberculosis: a controlled trial; final report to the research committee of the Tuberculosis Society of Scotland. BMJ 1960; 5215: 1751-1756.
15. British Tuberculosis Association, Research Committee. A trial of corticotrophin and prednisone with chemotherapy in pulmonary tuberculosis. Tubercle 1961; 42: 391-412.
16. United States Public Health Service, Tuberculosis Therapy Trial. Prednisone in the treatment of pulmonary tuberculosis. Am Rev Respir Dis 1965; 91: 329-338.
17. Citron K M, Girling D J. Tuberculosis. In: Weatherall D J, Ledingham J G G, Warrell D A, eds. Oxford Text Book of Medicine, 2nd ed. Oxford: Oxford Medical Publications, 1987.
18. American Thoracic Society, Medical Section of the American Lung Association. Treatment of tuberculosis and tuberculosis infection in adults and children. J Respir Crit Care Med 1994; 149: 1359-1374.
19. Ormerod L P. Chemotherapy of tuberculosis. In: Wilson R. ed. Tuberculosis, European Respiratory Monograph. Sheffield: ERS Journals Ltd, 1997: pp 290-291.
20. Weinstein H J, Koler J J. Adrenocorticosteroids in the treatment of tuberculosis. N Engl J Med 1959; 260: 412-417.
21. Angel J H, Chu L S, Lyons H A. Corticotrophin in the treatment of tuberculosis: a controlled study. Arch Intern Med 1961; 108: 75-91.
22. Marcus H, Yoo O H, Akyol T, et al. A randomized study of the effects of corticosteroid therapy on healing of pulmonary tuberculosis as judged by clinical, roentgenographic, and physiologic measurements. Am Rev Respir Dis 1962; 88: 55-64.
23. British Tuberculosis Association, Research Committee. Trial of corticotrophin and prednisone with chemotherapy in pulmonary tuberculosis: a 2-year radiographic follow-up. Tubercle 1963; 44: 484-486.
24. Johnson J R, Taylor B C, Morrissey J F, et al. Corticosteroids in pulmonary tuberculosis. Am Rev Respir Dis 1965; 92: 376-391.
25. Malik S K, Martin C J. Tuberculosis, corticosteroid therapy, and pulmonary function. Am Rev Respir Dis 1969; 100: 13-18.
26. Indian Council of Medical Research, Tuberculosis Research Center. Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India. Tubercle 1983; 64: 73-91.
27. Smithwick R W. Laboratory manual for acid-fast microscopy. 2nd ed. US Dept of Health, Education and Welfare, PHS. Atlanta: Centers for Disease Control, 1976.
28. Masud T, Kemp E. Corticosteroids in treatment of disseminated tuberculosis in patient with HIV infection. BMJ 1988: 296: 464-465.
29. Chung K F, Snashall P D. Suppression of fever during treatment of pulmonary tuberculosis: importance of using twice versus single daily dose of prednisone. Postgrad Med J 1983; 59: 373-375.
30. Edwards D M, Courtenay-Evans R J, Galley J M, et al. Changes in cortisol metabolism following rifampicin therapy. Lancet 1974; 2: 549.
31. Lee C H, Wang W J, Lan R J, et al. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled, randomized trial. Chest 1988; 94: 1256-1259.
32. Rohwedder J J. Upper respiratory tract tuberculosis. In: Schlossberg D, ed. Tuberculosis. 3rd ed. New York: Springer-Verlag, 1993: pp 107-113.
33. Wyser C, Walzl G, Smedema J P, Swart F, van Schalkwyk E M, van de Wal B W. Corticosteroids in the treatment of tuberculous pleurisy. Chest 1996; 110: 333-338.
34. Rook G A W, Bloom B R. Mechanisms of pathogenesis in tuberculosis. In: Bloom B R. ed. Tuberculosis: pathogenesis, protection and control. Washington: American Society for Microbiology, 1994: pp 485-501.
35. Thompson J E. The management of hypersensitivity reactions to antituberculosis drugs. Med J Aust 1969; 2: 1058-1063.